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ABSTRAK (BAHASA MALAYSIA) 
Topik 
IMPAK KRANIOPLASTI PADA PENGALIRAN DARAH SEREBRUM DAN 
HUBUNGANNYA DENGAN HASIL KEPUTUSAN KLINIKAL KEATAS PESAKIT YANG 
PERNAH MENJALANI PEMBEDAHAN DIKOMPRESI KRANIEKTOMI 
Latar belakang 
Dikompresi kraniektomi kerap dijalankan keatas pesakit yang mempunyai hypertensi otak yang 
gagal dirawat secara perubatan. Adalah amalan biasa di Malaysia dan seluruh dunia, pesakit 
yang pernah menjalani dikompresi kraniektomi akan menjalani pembedahan kranioplasti. 
Peningkatan hasil keputusan klinikal telah diperhatikan di antara pesakit yang menjalani 
kranioplasti. Pemulihan pengaliran darah serebrum telah dinyatakan sebagai salah satu factor 
yang menyebabkan peningkatan hasil keputusan klinikal selepas kranioplasti. Oleh yang 
demikian, kajian ini dijalankan untuk menentukan impak kranioplasti terhadap pengaliran darah 
serebrum dan hubungannya dengan hasil keputusan klinikal keatas pesakit yang pernah 
menjalani pembedahan dikompresi kraniektomi. 
Objektif 
Tujuan kajian ini adalah untuk menilai pengaruh kranioplasti terhadap pengaliran darah 
serebrum dengan menggunakan CT perfusi pada pesakit yang pernah menjalani  pembedahan 
dikompresi kraniectomi. Selain itu, impak kranioplasti terhadap hasil keputusan klinikal 
berdasarkan GOS, MMSE dan FAB turut dinilai. Seterusnya, ini membolehkan hubungan antara 
pengaliran darah serebrum dan hasil keputusan klinikal dinilai. 
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Kaedah Kajian 
Kajian ini adalah kajian prospektif secara pemerhatian dikalangan pesakit yang telah menjalani 
pembedahan dekompresi kraniektomi untuk tujuan hypertensi otak dan memerlukan pembedahan 
kranioplasti di Hospital Sungai Buloh. Kajian ini dijalankan dari 1hb September 2013 sehingga 
1hb September 2014 di mana seramai 22 pesakit terlibat dalam kajian ini. Kesemua pesakit akan 
menjalani CT perfusi untuk menentukan nilai pengaliran darah serebrum semasa kemasukan ke 
wad untuk kranioplasti. Selain itu, hasil keputusan klinikal turut akan diuji menggunakan skala 
GOS, MMSE dan FAB. Rawatan susulan adalah pada 6 dan 24 minggu selepas kranioplasti. CT 
perfusi dan pemeriksaan keputusan klinikal dijalankan pada rawatan susulan 6 minggu selepas 
kranioplasti, manakala hanya pemeriksaan keputusan klinikal dijalankan pada rawatan susulan 
24 minggu selepas kranioplasti. Keputusan dan data dalam kajian ini dianalisa dengan 
menggunakan aplikasi SPSS versi 12.0.1. 
Keputusan 
Nilai median pengaliran darah serebrum pada sebelah ipsilateral sebelum kranioplasti adalah 
48.87 (IQR 25.05) ml/min/100g dan bertambah kepada 61.10 (IQR 31.65) ml/min/100g 6 
minggu selepas kranioplasti.  Perbezaan ini adalah terbukti secara statistik dengan nilai p<0.001. 
Pada sebelah kontralateral, nilai median pangaliran darah sebelum kranioplasti adalah 60.55 
(IQR 23.61) ml/min/100g dan telah bertambah kepada 71.84 (IQR 24.59) ml/min/100g 6 minggu 
selepas kranioplasti, dengan nilai p<0.001. Nilai median GOS adalah 4, sebelum kranioplasti, 6 
dan 24 minggu selepas kranioplasti. Nilai median yang sama ini, adalah terbukti secara statistik 
sebelum kranioplasti kepada 6 dan 24 minggu selepas kranioplasti dengan nilai p=0.046 dan 
p=0.014 masing-masing. Mini mental state examination (MMSE) pula menunjukkan nilai 
xiv	  
	  
median 22 (IQR 12.75) sebelum kranioplasti, 25 (IQR 12.50) 6 minggu selepas kranioplasti dan 
25.5 (IQR 13.00) 24 minggu selepas kranioplasti. Perbezaan nilai median MMSE sebelum 
kranioplasti kepada 6 dan 24 minggu selepas kranioplasti adalah terbukti secara statistik dengan 
nilai p=0.001 dan p<0.001. Nilai median FAB adalah 12 (IQR 10.75) sebelum kranioplasti, 14.5 
(IQR 11.35) 6 minggu selepas kranioplasti dan 15 (IQR 11.25) 24 minggu selepas kranioplasti. 
Perbezaan nilai median FAB sebelum kranioplasti kepada 6 dan 24 minggu selepas kranioplasti 
adalah terbukti secara statistic dengan p=0.002 dan p=0.001 masing-masing. Korelasi diantara 
pengaliran darah serebrum dan hasil keputusan klinikal adalah tidak signifikan dengan nilai 
p>0.05.  
Kesimpulan 
Pada masa dahulu, kranioplasti diketahui sebagai pembedahan yang mampu memulih-baikan 
kecacatan tengkorak untuk memberi perlindungan kepada otak dan nilai cosmesis. Kajian ini, 
menunjukan kranioplasti memberi peningkatan kepada pengaliran darah serebrum pada sebelah 
ipsilateral dan kontralateral. Selain itu, kami juga mampu membuktikan nilai therapeutik 
kranioplasti terhadap peningkatan  hasil keputusan klinikal dalam kajian ini. Walaupun, kami 
tidak dapat menunjukan korelasi yang kukuh diantara pengaliran darah serebrum dengan 
peningkatan hasil keputusan klinikal, kesimpulan hasil kajian kami setakat ini mampu 
memberikan pedoman awal mengenai peranan penting kranioplasti terhadap peningkatan perfusi 
otak dan hasil keputusan klinikal. Kami berharap pada masa hadapan, ini akan menjana minat 
dikalangan saintis untuk menjalankan multi-centered randomized trial dengan melibatkan lebih 
pesakit, bagi tujuan memperkukuhan lagi kesimpulan kajian ini. Berdasarkan kesimpulan kajian 
ini, kami menyaran agar pembedahan kranioplasti patut disyorkan kepada semua pesakit yang 
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pernah menjalani dikompresi kraniektomi bagi tujuan meningkatan pengaliran darah serebrum 
dan hasil keputusan klinikal, selain mampu memberi perlindungan otak dan nilai cosmesis. 
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ABSTRACT (ENGLISH) 
Title 
THE IMPACT OF CRANIOPLASTY ON CEREBRAL BLOOD FLOW AND ITS 
CORRELATION WITH CLINICAL OUTCOME IN PATIENTS UNDERWENT 
DECOMPRESSIVE CRANIECTOMY 
Background 
Decompressive craniectomy are commonly use as the treatment for medically refractory 
intracranial hypertension. It is a common practice in Malaysia and worldwide, that patient will 
have subsequent reconstructive cranioplasty. Unexpected improvement in patient’s neurological 
status has been observed among patients that underwent cranioplasty procedure. Restoration of 
CBF hemodynamics is one of the factors said to affect patient’s clinical outcome post-
cranioplasty. Therefore, this study was conducted to determine the impact of cranioplasty on 
CBF and its correlation with clinical outcome in patients undergoing decompressive 
craniectomy. 
Objectives 
This study was done to evaluate the effect of cranioplasty on CBF with CT perfusion in patients 
with previous decompressive craniectomy undergoing cranioplasty.  Besides that, the effect of 
cranioplasty on clinical outcome based on GOS, MMSE & FAB was also evaluated. This study 
also aimed to determine the correlation between post-cranioplasty CBF and clinical outcome.  
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Methodology 
A prospective observational study was done on patients who have underwent decompressive 
craniectomy for intracranial hypertension and requiring reconstructive cranioplasty at Hospital 
Sungai Buloh. This study was conducted between 1st September 2013 and 1st September 2014 
and a total of 22 patients were included in this study. During admission, all patients had CT 
perfusion done to determine pre-cranioplasty CBF. Clinical outcome was assessed using GOS, 
MMSE and FAB. Subsequent, follow up was done at 6 weeks and 24 weeks post-cranioplasty. 
At 6 weeks post cranioplasty follow up, a repeat CT perfusion scan and assessment of clinical 
outcome was performed. During the 24 weeks post-cranioplasty follow up, only clinical outcome 
was evaluated. Data entry and analysis was done using Statistical Package for Social Sciences 
(SPSS) version 12.0.1.  
Results 
The median value of the ipsilateral cortical CBF was 48.87 (IQR 25.05) ml/min/100g and 61.10 
(IQR 31.65) ml/min/100g at pre-cranioplasty and 6 weeks post-cranioplasty respectively 
(p<0.001). Similarly for contralateral cortical CBF, which showed improvement from 60.55 
(IQR 23.61) ml/min/100g to 71.84 (IQR 24.59) ml/min/100g at 6 weeks post-cranioplasty 
(p<0.001). No difference seen in the median value for GOS which was 4 at pre, 6 and 24 weeks 
post-cranioplasty with p=0.046 and p=0.014 respectively. Median value for MMSE showed 
significant difference with value of 22 (IQR 12.75), 25 (IQR 12.50) and 25.5 (IQR 13.00) at pre-
cranioplasty, 6 and 24 weeks post-cranioplasty respectively (p=0.001 and p<0.001). Median 
value for FAB was 12 (IQR 10.75) at pre-cranioplasty, 14.5 (IQR 11.35) at 6 weeks post-
cranioplasty and 15 (IQR 11.25) at 24 weeks post-cranioplasty. The difference at pre-
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cranioplasty to 6 and 24 weeks post-cranioplasty was significant with p=0.002 and p=0.001 
respectively. No significant correlation between CBF and clinical outcome (p>0.05).  
Conclusion 
Cranioplasty in the past is known as a surgical procedure that restore cranial defect to provide 
cerebral protection and cosmesis. In our present study, it suggests that cranioplasty can 
remarkably improve cortical perfusion for both the ipsilateral and contralateral hemisphere. 
Besides that, we also believe that cranioplasty has a therapeutic role in terms of clinical outcome 
improvement which was observed in our study.  Even though, we are unable to establish a strong 
positive correlation between improved cerebral blood flow and clinical outcome, the results 
obtained so far may shed light on the significant role of cranioplasty on the improvement of 
cerebral perfusion and clinical outcome. This we hope will generate interest among future 
researchers to carry out multi-centered randomized trials which can analyze a larger number of 
patients to further draw a concrete conclusion to support our claim. Based on this study, we 
would like to propose that cranioplasty should be done to all patients with previous history of 
decompressive craniectomy to improve cerebral perfusion and clinical outcome as it also 
provides cerebral protection and cosmetic correction. 
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CHAPTER ONE: INTRODUCTION 
Decompressive craniectomy procedure has recently experienced a renewed interest among 
neurosurgeons worldwide.  Patients underwent DC have remarkably increased in number over 
the last few decades, as more studies has shown its effectiveness in reducing mortality rate, by 
reducing the adverse effects of severe cerebral edema and swelling (Venes and Collins, 1975; 
Cooper et al., 1976). 
Relief of intracranial pressure by DC was first described by Cushing in the early 20th century 
(Cushing, 1908). Since then surgical decompressive has been advocated as a treatment for severe 
brain edema associated with brain injury and infarction (Ransohoff et al., 1971). Decompressive 
craniectomy is described as the removal of an area of skull bone with the objective of converting 
the ‘closed’ intracranial compartment into an ‘open’ compartment.  Current and widely 
acceptable modalities for the treatment of increased ICP include medical management such as 
30-degree head up, sedation, hyperventilation, osmotic diuresis, barbiturate-induced coma and 
surgical management such as cerebrospinal fluid (CSF) drainage and DC (Honeybul et al., 
2010). 
Many published articles demonstrated good surgical outcome following cranioplasty, however 
till today there are no clearly defined indication for, or optimal timing of the procedure (Reddy et 
al., 2002). Decompressive craniectomy has most commonly been performed in patient with 
traumatic brain injury and ischemic stroke associated with intractable intracranial hypertension. 
Other indications, which are less frequently described, include meningitis, subdural empyema, 
encephalitis, acute disseminated encephalomyelitis and cerebral venous and dural sinus 
thrombosis. 
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 Decompressive craniectomy if performed early, has been shown to reduce mortality, improves 
functional recovery, reduces the duration of stay in intensive care unit and improves Barthel 
Index Score(Kunze et al., 1998). These effects are thought to be due to improved collateral 
circulation, reduction in tissue edema and improvement in oxygenation and energy metabolism 
in injured tissues (Zweckberger et al., 2003). 
Decompressive craniectomy is not without its own morbidity. In some studies it has been 
reported as much as 50% complication rate postoperatively (Yang et al., 2008).  A very 
important drawback of DC is the increased risk of brain injury. Honeybul reports a case of a 
middle-aged man who had DC following traumatic brain injury as a result of fall. The patient 
was making good recovery when he unfortunately fell a second time on the unprotected 
craniectomy site. As a consequence, he succumbed to the injury (Honeybul, 2009). This case 
highlights the need for reconstructive cranioplasty after decompressive craniectomy for cerebral 
protection. Besides that, patient who undergoes DC will subsequently require cranioplasty 
resulting in the need for 2 surgeries, the first being the removal of the bone flap and the second to 
repair the defect (cranioplasty). This is also a potential cause of concern since cranioplasty has 
also been associated with a number of known surgical and anesthetic complications.  
One particular major complication that has been associated with DC is the syndrome of sinking 
skin flap (SSSF) described by Yamaura and Makino (Yamaura and Makino, 1977) . The SSSF is 
characterized by neurological symptoms (headache, epileptic seizures, vertigo, dysesthesias, or 
paresis) which develop over weeks to months after large a DC. There are also few reports of a 
syndrome characterized by subjective symptoms such as headache, dizziness, undue fatigability 
and vague discomfort are known collectively as the syndrome of the trephined (ST). Both the 
symptoms of SSSF and ST are said to improve rapidly following cranioplasty. Therefore, this 
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leads to the hypothesis that the mechanism of onset for both the syndromes may be similar 
(Hodozuka et al., 2000). It is the brain tissue compression as the result of lower intracranial 
pressure in the upright position and higher atmospheric pressure causing pressure gradient 
difference which acts on the cranial defect. Various theories on the pathophysiology of the 
syndrome have been described including a) direct cortical compression, b) hydrodynamically 
disturbed CSF parameters, c) hemodynamically reduced cerebral blood flow, cerebrovascular 
reserve capacity, and venous return as a result of pressure in the vasculature and brain tissue, 
d)disturbed metabolism. Besides that other known complications of DC include contralateral 
subdural effusions, infections (such as meningitis or brain abscess) and hydrocephalus. Persistent 
vegetative state is probably one of the most devastating outcomes following DC (Stiver, 2009).  
Currently the main indications for cranioplasty are cosmetic reconstruction and cerebral 
protection. Cranioplasty is usually performed several months after DC with lack of specific 
guidelines on the timing of surgery. Unexpected improvements in patients neurological status 
has been observed in many centers. Suzuki et al reported five out of six patients actually showed 
improvement in neurological signs after cranioplasty (Suzuki et al., 1993). These findings were 
also supported by Maekawa et al who reported improvement of neurological outcome in five of 
the eight patients post cranioplasty (Maekawa et al., 1999). Till date the mechanism of 
improvement remains unclear. Yamamura et al in 1977 suggested that atmospheric pressure is 
transmitted to the cranial cavity through the cranial defect, causing inward rotation of the scalp 
(Yamaura and Makino, 1977). This pressure on the cranial defect can thus cause neurological 
deficit. The unprotected brain compression through the cranial defect by the atmospheric 
pressure can be normalized by cranioplasty (Wee and Kuo, 2014). 
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Improvement in cerebral perfusion after cranioplasty has since been established by many 
modalities.  Yoshida et al in their studies using 133Xe CT and 31P magnetic resonance 
spectroscopy concluded that cranioplasty was able to improve cerebral blood flow and energy 
metabolism. Cerebral perfusion improvement after cranioplasty has also been shown by several 
other studies using trans-cranial Doppler (Winkler et al., 2000; Chibbaro et al., 2013; Wee and 
Kuo, 2014). More recently the use of CT perfusion imaging to measure CBF has been gaining 
popularity. This modality is generally easier to be performed and less operator dependent 
compared to transcranial Doppler and 133Xe CT. Excellent cooperation from the patient is also 
needed if technique of measuring CBF is by using 133Xe CT. Besides that, CBF measurement 
using CT perfusion gained much attention partly due to the improved helical scanning, CT scan 
machine and advances in the software used to analyse the data which aid in the accuracy and 
ease of performing (Sakamoto et al., 2006). The procedure is also minimally invasive with only 
intravenous administration of iodinated contrast material. More importantly, CT perfusion has 
been validated and proven to have excellent correlation with 133Xe CT in the measurement of 
CBF (Wintermark et al., 2001) . CT perfusion measurement of cranioplasty related perfusion 
changes were done by Sakamoto et al in 2006 and Sarubbo et al in 2014 (Sakamoto et al., 2006; 
Sarubbo et al., 2014) 
In most neurosurgical center in Hospital Sungai Buloh and Malaysia, all patients that have 
undergone previous DC, will be treated similarly. All of the patients will eventually undergo 
reconstructive cranioplasty later, except for those with poor recovery (remained vegetative) or 
those who are elderly. The Department of Neurosurgery Hospital Sungai Buloh is the first in the 
country to be equipped with a brain suite that has been fully operational since the 10th of January 
2011. CT perfusion imaging modality is available in the brain suite which enable intraoperative 
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perfusion mapping to be done. This study is done with the aim, to further establish the hypothesis 
that cranioplasty not only provides cerebral protection and cosmesis but also improve cerebral 
blood flow and clinical outcome.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
6	  
CHAPTER TWO: LITERATURE REVIEW 
DECOMPRESSIVE CRANIECTOMY 
Decompressive craniectomy is used for management of various neurological emergencies 
(Brown et al., 2008). This surgery is done by removing part of the skull to provide space for the 
injured and oedematous brain to expand and thus reducing intracranial hypertension. This is done 
to prevent the unavoidable sequelae of cerebral herniation in the event of uncontrolled 
intracranial hypertension. At the same time, cerebral perfusion can be improved (1996; Faul et 
al., 2007). 
Decompressive craniectomy is used for various conditions and commonly for traumatic brain 
injury, middle cerebral artery infarction and many others more. In 1901, Kocher reported the use 
of the large craniectomy for the treatment of cerebral oedema secondary to traumatic head injury 
which failed medical therapy (Kjellberg and Prieto, 1971). This technique was subsequently 
abandoned due to the high postoperative complication rate but is now widely used and has been 
the subject of numerous positive published series.  
It is undeniable that DC has become widely accepted in the management of severe traumatic 
head injury. However, such a major procedure is not without its own list of complications. Most 
papers have concentrated on treatment of intracranial hypertension and outcome and relatively 
few have detailed the complications of the decompressive procedure (Yang et al., 2008; 
Honeybul et al., 2009). Among the complications known are such as surgical wound infection, 
herniation through the craniectomy defect, subdural/subgaleal effusion, syndrome of the 
trephined (ST), hydrocephalus, post traumatic seizures, hydrocephalus and rarely mortality 
(Honeybul and Ho, 2011).  
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The role of DC remains an unanswered question and has yet to be clearly defined if one 
considers the benefit and risk that comes with the procedure. What is less certain is whether there 
comes a point where the benefit of lowering the intracranial pressure outweighs the morbidity of 
surgery and therefore contributing to the improvement in patient’s clinical outcome (Brown et 
al., 2008). 
 
CRANIOPLASTY 
History: 
History of cranioplasty dates back to 7000 B.C. (Shah et al., 2014). In current modern 
neurosurgical practice patients who survived a DC will eventually require a cranioplasty, except 
in those who remained vegetative or elderly. However, many recent literatures regarding 
cranioplasty are based on case series that emphasize on the technical aspects of the procedure 
with minimal emphasis on clinical outcomes and perioperative complications of the procedure. 
Archeologic findings show that cranioplasty using inorganic materials started way before the use 
of organic materials. Beginning from the 19th century, the use of autologous bones from various 
donor sites such as the ribs and tibia, has gained wide popularity along with the use of other 
materials such as titanium and methyl methacrylate.  
Materials of cranioplasty: 
The choice of implant material for cranioplasty has long been controversial with no concrete 
evidence to suggest which is superior. Either alloplastic material or an autogenous bone has been 
used for reconstructive cranioplasty. Alloplastic materials are popular for uncomplicated primary 
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cranioplasty as it requires no donor site morbidity and has no complications related to donor site 
(Lee et al., 1995). However, it acts as a permanent avascular foreign body and therefore 
contraindicated in problematic recipient beds such as dirty or infected wounds. Among the most 
frequently used alloplastic materials are hydroxyapatite cements, acrylics, titanium and carbon 
fiber-reinforced plastics (van Putten and Yamada, 1992).  On the other hand, fresh autogenous 
bone reconstruction has been advocated because of its ability to become incorporated as living 
tissue with reparative capabilities.  In comparing autologous bone kept in abdominal 
subcutaneous plane with the ones kept in tissue bank, there was no statistical difference between 
the two groups (Cheng et al., 2014) . The similar studies also showed where bone is kept in the 
tissue bank, the operation time and mean estimated blood loss was significantly less compared to 
those with bone kept in the abdominal wall. 
An ideal cranioplasty material must have the following features (Blake, 1994): 
• It must fit the cranial defect and achieve complete closure 
• Radiolucency 
• Resistance to infections 
• Not dilated with heat 
• Strong against biomechanical processes 
• Easy to shape 
• Not expensive 
• Ready to use 
• At present, there is still no perfect material to fit all these criteria. 
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Timing: 
An optimal time of cranioplasty following craniectomy is intensely debated and inconclusive. 
Many studies showed no difference in terms of outcome when cranioplasty is performed at less 
than 12 weeks, 12-24 weeks and more than 24 weeks. Basheer et al showed that even though the 
differences were not statistically significant, patients who underwent cranioplasty after 24 weeks 
had more complications compared to the other 2 groups. However, in another study, the time of 
cranioplasty in between 16 to 20 weeks was shown to carry the highest risk of complications 
(Piedra et al., 2014). 
Complications: 
The incidence of complications after cranioplasty varies and has been reported to range from 
12% to 50% (Moreira-Gonzalez et al., 2003; Matsuno et al., 2006). Cranioplasty failure 
manifests with poor aesthetic results and inadequate cerebral perfusion. The overall complication 
rate is high, as reported by various studies (Sorensen et al., 2003). As reported by Walcott et al, 
the complication rate of 23.8% was noted in a retrospective analysis to identify all complications 
related to cranioplasty and the influence of specific risk factors on the infection rate (Walcott et 
al., 2013). Among the complications reported were hematoma, wound healing disturbance, 
surgical site infection, hydrocephalus, seizure and death.  
Implant infection is the leading cause to cranioplasty failure. This risk can be minimized by 
securing a well vascularized, soft tissue cover, sealing any communication with the paranasal 
sinuses. A previously infected bed should be left to mature and confirmed clearance of bacterial 
foci, before any cranioplasty is to be carried out. After a routine cranioplasty, a 4-5% incidence 
of infection has been reported (Rish et al., 1979). However, patients with a history of infection 
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have an up to eight-fold increased risk of reinfection with subsequent cranioplasty. When surgery 
was delayed longer than 1 year, the incidence of infection approached that of routine 
cranioplasty.   
 
SYNDROME OF SINKING SKIN FLAP  
The syndrome of ‘trephined’ (ST) or the syndrome of ‘sinking skin flap’ (SSSF) was first 
reported by Yamaura in literature in the year 1977 (Yamaura et al., 1977). It is characterised by 
symptoms such as headache, epileptic seizures, vertigo, dysesthesias or paresis, which happens 
following extensive decompressive craniectomy. 
Many attempts have been made to try to explain the pathophysiology of this condition. 
Previously it was believed that atmospheric pressure is directly transmitted to the intracranial 
cavity, causing an inward shifting of the scalp over the craniectomy site (Kwon et al., 2012). 
However recently it has been proposed that a negative gradient between atmospheric and 
intracranial pressure, which is aggravated by changes in the CSF compartment following CSF 
hypovolemia to be the mechanism of neurological deterioration after craniectomy (Akins and 
Guppy, 2008).  
The goal of treatment in syndrome of sinking skin flap is to restore the pressure exerted by 
depression of the craniectomy site (Schwab et al., 1998). According to the Monro-Kellie’s Law, 
there is a reciprocal relationship between the volumes of brain tissue, blood and CSF which 
assures the equilibrium in the intracranial contents. Therefore, it is important to establish a 
physiological relationship between the brain structures in order to reinstitute a normal 
intracranial condition after cranioplasty. This can be achieved by injection of physiological 
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saline solution to replace the ‘lost’ quantity of ventricular CSF (Stula, 1982). Conservative 
management of sinking skin flap syndrome with neurological deterioration is largely ineffective. 
Cranioplasty is the principal surgical treatment that could improve the neurological deficits by a 
decrease in local intracranial pressure, and correction of abnormal CSF dynamics with 
subsequently reversal of symptoms (Sakamoto et al., 2006).   
 
NEUROPSYCHOLOGICAL ASSESSMENTS 
Improvement in clinical outcome following reconstructive cranioplasty has been observed in the 
past. A 57 year old female presented with gait disturbance and poor activity who was diagnosed 
with SSSF was reported to recover well 2 weeks after cranioplasty (Sakamoto et al., 2006). 
Various studies have used the Glasgow outcome scale (GOS), frontal assessment battery (FAB) 
and mini mental state examination (MMSE) for the evaluation of the neurology and cognition of 
patients undergoing cranioplasty after craniectomy. All these are bedside evaluations which can 
be carried out easily within a few minutes. A study carried out to evaluate impact of early 
cranioplasty on CBF and metabolism and its correlation with neurological and cognitive outcome 
concluded that 91% of its patients showed a clear and remarkable neuro-cognitive improvement 
tested by GOS, FAB and MMSE in the post-cranioplasty period (Chibbaro et al., 2012). A 
similar study was repeated in 2013 also showed corresponding findings  with statistically 
significant neurological and cognitive improvement was observed in 92% of patients following 
cranioplasty following assessment with the above tests (Chibbaro et al., 2013). 
 
 
12	  
Glasgow Outcome Scale (GOS) 
The GOS was originally described in 1975. It is now widely used for classification of outcome of 
patients with traumatic brain injury whereby it is used by both acute care and rehabilitation 
specialists to assess recovery (Jennett and Bond, 1975). It is a multi-dimensional scale which 
assesses 5 categories: dead, vegetative (cannot interact, unresponsive), severely disabled (can 
follow commands, cannot live independently), moderately disabled (can live independently, 
reduced work capacity) and good recovery (can work) (Jennett et al., 1977).  The outcome is 
further divided into poor outcome (dead, vegetative and severely disabled) and good outcome 
(moderately disabled and good recovery). However it was noted that the original GOS is 
insensitive to small changes in functional status which are clinically relevant (James W, 2012). 
The extended version separates each of the three higher function categories into two, making 
eight categories in total (Heiskanen and Sipponen, 1970). Due to its popularity, the GOS 
remained widely used in multiple studies for assessment of patient’s functional status post 
craniectomy and cranioplasty. 
 
Mini Mental State Evaluation (MMSE) 
The MMSE is used to assess cognitive function in neurology. As a detailed assessment of 
cognition is time consuming and requires a high standard of specialty, it is desirable to have a 
standardised simple and quick test to be routinely used (Dick et al., 1984). Thus the MMSE was 
designed for a quick and accurate assessment. It is a quick test which takes approximately seven 
minutes to complete (Royall et al., 1998). Despite its simplicity, it is able to test a broad range of 
cognitive functions which include orientation, recall, attention, calculation, language orientation, 
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recall, attention, calculation, language manipulation and constructional apraxia (Zarina ZA, 
2007). The MMSE is shown to have a good reliability and validity among patients in the United 
States. However, problems can arise if it is used in a language other than English. The validity 
may be doubtful in a different cultural setting, especially where literacy is low (Kua and Ko, 
1992).  It also fails to identify executive dysfunction if it is quite severe (Angela J, 2002).  This is 
because these groups of patients can still have a normal MMSE score but have severe functional 
limitations. 
Even though the MMSE has been widely used to assess psychiatric patients, it has also gain its 
popularity among neurosurgical patients. The Koreans have used this test to assess the cognitive 
function among neurosurgical patients with various cerebral pathologies and treatments in an 
outpatient clinic. It has also been used to assess the cognitive function of patients with traumatic 
brain injury who underwent neurosurgical interventions. In Malaysia, the English version of 
MMSE was found not suitable due to language barrier and culture differences. Thus it was 
translated into the Malay language using the forward and backward translation method and was 
tested among 185 patients selected from 8 old folks home across Malaysia (Zarina ZA, 2007). 
This was the first study that translated the MMSE into the Malay language. Another validation 
study was done in 2009 among Malay speaking elderly population in Malaysia (Ibrahim et al., 
2009).  
 
Frontal Assessment Battery (FAB) 
The diagnosis and prognosis of brain diseases such as frontotemporal dementias and the severity 
of brain injuries can be accessed via the frontal lobe function (Dubois et al., 2000). However, the 
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function of the frontal lobe can be difficult to be assessed clinically. It controls conceptualization 
and abstract reasoning, lexical verbal fluency and mental flexibility, motor programming and 
executive control of action, self-regulation and resistance to interference, inhibitory control and 
environmental autonomy. A bedside test called the frontal assessment battery was designed to 
specifically assess the frontal lobe function. It consists of six neuropsychological tasks which 
were pioneered by Luria, Lhermitte, Pillon and Serdaru (Kopp et al., 2013) . Since then, the FAB 
has become increasingly popular for a variety of application in neurology, most notably the early 
diagnosis of neurodegenerative dementing diseases.  A validation study was performed with 
patients suffering from different degenerative disorders known to involve the frontal lobes and 
showed that the FAB is a sensitive tool for these conditions (Appollonio et al., 2005). It has also 
been used to assess the cognitive outcomes and activity of daily living among neurosurgical 
patients with intrinsic brain injury, whereby it showed satisfactory discriminating power. 
 
CEREBRAL PERFUSION CHANGES WITH CRANIOPLASTY 
Ever since improved neurological and functional outcome has been noted following 
reconstructive cranioplasty, various theories have been postulated for the phenomenon. 
Impairment of cerebral perfusion by means of cerebral blood flow was postulated as one of the 
mechanism seen in SSSF (Yamaura and Makino, 1977). Few studies in the past were done to 
evaluate the impact of cranioplasty on cerebral blood flow. 
Improvement in dynamics of cerebral blood flow and metabolism in patients with cranioplasty 
was published back in 1996 (Yoshida et al., 1996). Yoshida et al was able to demonstrate post-
cranioplasty bilateral increase in CBF by using 133Xe CT.  Improved middle cerebral artery blood 
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flow velocity was noted in the operative hemisphere and contralateral hemisphere 7 days after 
cranioplasty in a study done by Winkler et al. He used transcranial Doppler ultrasonography to 
assess the difference in middle cerebral blood flow velocity between pre and post-cranioplasty 
(Winkler et al., 2000). Similar findings of improved middle cerebral blood flow velocity on both 
hemispheres were also found in few studies done later, to further support this claim (Chibbaro et 
al., 2012; Chibbaro et al., 2013; Wee and Kuo, 2014).    
More recently assessment of CBF using CT perfusion is gaining popularity due to the fact that it 
is less cumbersome to be performed and doesn’t require high patient cooperation. It only 
involved simple intravenous contrast administration. Besides that, the advancement in helical 
scanning, CT scan machine and advances in the software used to analyze the data contribute to 
the accuracy in this modality. Single validation study has also been carried out to suggest the 
good correlation between CT perfusion and Xe CT (Wintermark et al., 2001).  Sakamoto et al 
reported a case of improved CBF using CT perfusion in a patient with SSSF after undergoing 
cranioplasty (Sakamoto et al., 2006). Improvement in clinical outcome and CBF assessment 
using CT perfusion and transcranial Doppler was also demonstrated by Chibbaro et al in his 
study (Chibbaro et al., 2013).  In that study, 24 patients undergoing craniectomy for severe head 
injury were evaluated after cranioplasty and statistically significant brain perfusion improvement 
was seen at 6 weeks follow up predominantly in the ipsilateral hemisphere. Another study also 
showed increment of CBF using CT perfusion 7 days after cranioplasty in stable traumatic brain 
injury patients (Sarubbo et al., 2014). However, in this study a drop in CBF was documented at 3 
months post-cranioplasty. The reason behind this finding was speculated to be due to the 
restoration of flow compatible with prevailing metabolic demand rather than worsening 
perfusion.  
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CHAPTER THREE: OBJECTIVES 
3.1 General objective 
The objective of this study is to evaluate between pre and post-cranioplasty CBF and clinical 
outcome and to correlate CBF with clinical outcome in patients with previous decompressive 
craniectomy undergoing cranioplasty. 
 
3.2 Specific objectives 
The specific objectives of this study are as follows: 
1. To evaluate pre and post-cranioplasty (1 day prior and 6 weeks post-cranioplasty) CBF 
by CT perfusion scan in the ipsilateral and contralateral hemispheres. 
2. To evaluate pre and post-cranioplasty (1 day prior, 6 and 24 weeks post-cranioplasty) 
clinical outcome by Glasgow outcome score (GOS), Frontal assessment battery (FAB) & 
mini metal state examination (MMSE) scores. 
3.  To correlate post-cranioplasty (6 weeks post-cranioplasty) CBF with clinical outcome. 
 
3.3 Research questions 
1. Is there improvement in CBF between pre and post-cranioplasty (1 day prior and 6 weeks 
post-cranioplasty) in ipsilateral and contralateral hemispheres? 
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2. Is there improvement in clinical outcome by GOS, FAB and MMSE scores between pre 
and post-cranioplasty (1 day prior, 6 and 24 weeks post-cranioplasty)? 
3. Is there any correlation between post-cranioplasty CBF and clinical outcome? 
 
3.4 Null Hypothesis 
1. There is no difference in CBF between pre and  post-cranioplasty (1 day prior and 6 
weeks post-cranioplasty) in ipsilateral and contralateral hemispheres 
2. There is no difference in GOS, FAB and MMSE scores between pre and post-
cranioplasty (1 day prior, 6 and 24 weeks post-cranioplasty)  
3. There is no correlation between post-cranioplasty CBF with clinical outcome 
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CHAPTER FOUR: METHODOLOGY 
4.1 Study design 
This is a prospective observational study on patients who have underwent decompressive 
craniectomy for intracranial hypertension requiring reconstructive cranioplasty at 
Hospital Sungai Buloh from the period of 1st September 2013 to 1st September 2014. 
 
4.2 Reference and source population 
All patients aged over 18 and up to 65 years who underwent decompressive craniectomy 
for intracranial hypertension and requiring reconstructive cranioplasty at Hospital Sg 
Buloh from 1st September 2013 to 1st September 2014.  They must also fulfill the 
inclusion criteria. 
 
4.3 Sampling frame and data collection 
Prior to recruitment, patients who underwent decompressive craniectomy for intracranial 
hypertension regardless of initial diagnosis and requiring reconstructive cranioplasty will 
undergo a face to face interview with their doctors in the clinic. Patients/Guardians will 
be informed regarding the nature of the study.  
It will be emphasized that there will be no change in their management or treatment for 
their primary condition regardless of their participation in this study. Having obtained 
their verbal consent, patients will be screened for eligibility. Once screening for 
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eligibility is completed, a written informed consent will be obtained from the patient (if 
applicable) and guardian, before they are enrolled in this study. 
 
4.4 Selection criteria 
The inclusion criteria are as follows: 
I. Patients over 18 and up to 65 years  
II. Patients underwent decompressive craniectomy for intracranial hypertension regardless 
of initial diagnosis (eg: severe head injury, subarachnoid hemorrhage, intracerebral 
hemorrhage, venous sinus thrombosis, malignant middle cerebral artery, tumor etc)  
III. Patients undergoing reconstructive cranioplasty 
IV. Patients/Guardian informed about the study and giving consent 
The exclusion criteria are as follows: 
• Patients age <18 or >65 years 
• Patients with previous bilateral decompressive craniectomy 
• Patients allergic to CT contrast products 
• Pregnant and nursing woman 
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4.5 Study schedule 
 All patients that were included in this study must first have an informed consent which 
fulfilled the requirement and reviewed by the Medical Research & Ethics Committee, Ministry 
of Health Malaysia (NMRR-12-1366-13599). The patient will then undergo a study schedule as 
follows: 
 4.5.1 Screening visit (during clinic follow up) 
I. Obtain both subject’s and guardian’s  signatures on study’s informed consent 
form 
II. Only guardian’s consent will be taken if subject is deem unfit for informed 
consent 
III. In the event that patient reverted to mentally capable for informed consent during 
the course of this study, informed consent will also be taken from subject with the 
presence of a guardian.  
IV. Obtain demographic information, medical history, allergy history to determine 
eligibility based on inclusion/exclusion criteria 
V. Ask for date of last menstrual period and do urine pregnancy test if required 
VI. Perform medical examination to determine eligibility 
VII. Schedule CT perfusion and clinical examination date for subjects who are eligible 
for the study. Provide subjects with instructions needed to prepare for the 
admission 
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    4.5.2 Admission (1-2 days prior to cranioplasty) 
I. Perform CT perfusion scan prior to cranioplasty 
II. Record clinical assessment (GOS, FAB, MMSE) prior to cranioplasty 
III. Subject will then proceed with cranioplasty as planned 
   4.5.3 Visit 1 (6 weeks post-cranioplasty) 
 I. Perform CT perfusions scan 
 II. Record clinical assessment (GOS, FAB, MMSE) 
 4.5.4 Visit 2 (24 weeks post-cranioplasty) 
 I.  Record clinical assessment (GOS, FAB, MMSE) 
 
4.6 Study procedure and evaluations 
4.6.1 CT perfusion evaluation 
CTP analysis was performed using 40-slice CT scanner (SIEMENS, SOMATOM 
Sensation Open) using a 40-s long continuous (cine) scan. One hundred and twenty axial 
images were constructed with three 9.6mm thick sections which covered a total of 
28.8mm from the level of foramen of Monro to the lateral ventricle. The CT scanner 
protocols were 80kV, 209mA, 1s per rotation and at zero degree gantry. The CTP scan 
was started with a 4s delay after the injection of 40ml of non-ionic contrast agent 
Iopamidol (BRACCO, Iopamiro 370) at a rate of 6ml/s with an infuser pump 
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(STELLANT, medrad). All CTP scans were analyzed with a software package using an 
imaging workstation (SIEMENS, Syngo multimodality workplace 2010A). CBF map was 
generated for each patient and was expressed in ml/min/100g. As shown in Figure 4.3 
CBF were measure in 3 circular regions of interest (ROIs) at a size of 1cm2, manually 
drawn on the plain CT brain and averaged CTP images in the ipsilateral hemisphere and 
then automatically reflected onto the contralateral hemisphere in the midline. In each 
patient, the CBF were averaged to generate a single value for each hemisphere. Below 
was the summary of CTP technical protocol: 
I. Cerebral blood flow (ml/100g/min) is assessed by CT perfusion scan (1 day prior and 6 
weeks post cranioplasty). 
II. CT scan with a 40-detector row scan (SIEMENS, SOMATOM Sensation Open) 
III. Workstation for image analysis (SIEMENS, Syngo multimodality workplace 2010A) 
IV. Scanning protocol: 
a. 3 contiguous 9.6mm slices in the region  of  interest (ROI) 
b. Continuous acquisition (cine) with 80 kVp and 209mA 
c. Duration of 40s with 1rotation/s 
d. Obtain 120 axial images 9.6mm thick 
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Figure 4.1: Patient undergoing CTP analysis performed using 40-slice CT scanner (SIEMENS, 
SOMATOM Sensation Open) (a,b)  
 
 
 
 
a	  
b	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V. Contrast media: 
a. At least 22-20G branulla     
b. Non-ionic contrast Iopamidol (Bracco, Iopamiro 370)  
c. 40ml of contrast with infusion rate of 6ml/s 
d. 50ml of Normal saline with infusion rate 6ml/s 
e. Time delay 4s from the beginning of the injection to the beginning of image 
acquisition 
 
 
 
 
 
 
 
 
Figure 4.2 (a): 40-detector row scan (STELLANT, medrad), (b): Non-ionic contrast 
Iopamidol (Bracco, Iopamiro 370)  
a	   b	  
